                                  DC REGULATIONS

D.C. MEDICAID PRIOR APPROVAL REQUIRED FOR SELECTED PHARMACEUTICALS PROVIDED TO
D.C. MEDICAID AMBULATORY CARE PATIENTS (§ 29-914)

914.1. Prior authorization from the D.C. Medicaid program shall be required
   for the dispensing of the following prescribed drugs to D.C. Medicaid
   ambulatory care patients:
   
   
   
   (a)	Oxycodone HC1 and Aspirin (more commonly known as Percodan);
   
   
   
   (b)	Flurazepam (more commonly known as Dalmane); and
   
   
   
   (c)	Oxycodone and Acetaminophen (more commonly known as Percocet and Tylox).

   914.2. Pharmacists shall request authorization from the Department of Human
   Services Office of Health Care Financing prior to dispensing to D.C. Medicaid
   patients any of the prescribed drugs identified in §914.1.

   914.3. For purposes of this section, the phrase “Ambulatory Care Patients”
   means a patient served through a system of primary care provided through
   outpatient facilities including services provided to patients who reside in
   intermediate care facilities for the mentally retarded. Ambulatory care does
   not include services provided in inpatient hospitals, skilled nursing
   facilities, intermediate care facilities or health maintenance organizations.
   
   
   
   	AUTHORITY: The authority for this section is D.C. Code, 2001 Ed. §1-307.02;
   Commissioner’s Order 70-83 (March 6, 1970), as amended by Mayor’s Order
   79-144 (July 11, 1979); and Reorganization Plan No. 2 of 1979, 3 D.C. Code,
   2001 Ed. at 338.
   
   
   
   	SOURCE: as amended by Final Rulemaking published at 34 DCR 4400 (July 10,
   1987).
